Published in Kidney Int on March 03, 2010
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol (2012) 1.98
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study. J Am Soc Nephrol (2015) 1.68
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy. Pediatr Nephrol (2014) 1.43
Nephrology in china. Nat Rev Nephrol (2013) 1.38
Oxford classification of IgA nephropathy: Broadening the scope of the classification. J Nephropathol (2012) 1.33
Oxford-MEST classification in IgA nephropathy patients: A report from Iran. J Nephropathol (2012) 1.32
Association between the proportion of globally sclerotic glomeruli and various morphologic variables and clinical data of IgA nephropathy patients. J Renal Inj Prev (2012) 1.20
Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med (2012) 1.19
Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol (2011) 1.17
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol (2011) 1.14
Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare. Clin Exp Nephrol (2016) 1.11
Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol (2012) 1.09
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int (2015) 1.04
Chapter 10: Immunoglobulin A nephropathy. Kidney Int Suppl (2011) (2012) 1.01
Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients. Int J Prev Med (2013) 0.98
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol (2012) 0.97
Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies. J Nephropathol (2013) 0.94
Renal vascular lesions in IgA nephropathy. J Renal Inj Prev (2013) 0.88
Henoch-Schönlein purpura nephritis. Pediatr Nephrol (2014) 0.86
Validation study of the Oxford classification for IgA nephropathy in Korean adults. Korean J Intern Med (2012) 0.86
Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence? J Renal Inj Prev (2013) 0.85
The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol (2014) 0.84
KIM-1 expression predicts renal outcomes in IgA nephropathy. Clin Exp Nephrol (2012) 0.83
Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling. BMC Nephrol (2013) 0.82
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Pediatr Nephrol (2016) 0.81
Biomarkers and targeted new therapies for IgA nephropathy. Pediatr Nephrol (2016) 0.78
The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy. Pediatr Nephrol (2014) 0.77
Clinicopathological and immunohistological features in childhood IgA nephropathy: a single-centre experience. Clin Kidney J (2013) 0.77
Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis. Indian J Nephrol (2016) 0.77
Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan. Clin Exp Nephrol (2015) 0.77
In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia. Nephron Extra (2017) 0.76
Globally sclerotic glomeruli in IgA nephropathy patients. J Renal Inj Prev (2012) 0.75
Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection. BMC Nephrol (2017) 0.75
Pathology: Oxford IgA nephropathy classification: valid for children? Nat Rev Nephrol (2010) 0.75
Mapping novel immunogenic epitopes in IgA nephropathy. Clin J Am Soc Nephrol (2014) 0.75
Comment on: Association between the proportion of globally sclerotic glomeruli and various morphologic variables and clinical data of IgA nephropathy patients. J Renal Inj Prev (2012) 0.75
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy. Clin Nephrol (2012) 0.75
Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease. J Immunol Res (2014) 0.75
Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects. World J Nephrol (2016) 0.75
Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience. Indian J Nephrol (2016) 0.75
IgA nephropathy with presentation of nephrotic syndrome at onset in children. Pediatr Nephrol (2016) 0.75
Inflammation in IgA nephropathy. Pediatr Nephrol (2017) 0.75
Long-term outcome of childhood IgA nephropathy with minimal proteinuria. Pediatr Nephrol (2015) 0.75
The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients. Clin Exp Nephrol (2017) 0.75
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol (2017) 0.75
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med (2010) 11.05
Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (2012) 10.53
VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med (2005) 8.49
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet (2013) 7.03
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol (2007) 6.13
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med (2013) 5.67
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest (2002) 5.42
The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum (2012) 4.80
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77